Trial Summary
What is the purpose of this trial?
This randomized trial aims to determine the effectiveness a virtual wellness intervention program in individuals with traumatic brain injury (TBI). Participants will be randomized at enrollment into two groups: immediate treatment (IT) and delayed treatment (DT) group. This study will also provide insights into the impact of these intervention's components in helping emotional, physical, and nutritional outcomes post-injury in the context of social determinants of health (SDOH).
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications, but it mentions that participants should not be starting a new treatment regimen that could affect the study. If your current treatment is stable, you may be eligible to participate.
What data supports the effectiveness of the MENTOR Wellness Program for TBI treatment?
The MENTOR Wellness Program may be effective because similar mentorship programs have shown to increase feelings of support, confidence, and satisfaction in medical residents, and a mentorship program for heart transplant patients was positively received, suggesting that mentorship can enhance patient care and well-being.12345
Is the MENTOR Wellness Program safe for humans?
How is the MENTOR Wellness Program for TBI different from other treatments?
The MENTOR Wellness Program for TBI is unique because it focuses on wellness and lifestyle interventions rather than traditional medical treatments. It likely incorporates elements such as exercise, nutrition, and mental health support, which are not standard in typical TBI treatments that often focus on medication or surgery.111121314
Research Team
Tamara Bushnik, PhD
Principal Investigator
NYU Langone Health
Eligibility Criteria
The MENTOR Wellness Program is for individuals who have had a traumatic brain injury (TBI) at least 12 months ago, can speak English or Spanish, and are medically cleared to participate. They must have internet access and not be in a minimally conscious state or starting new treatments that could affect the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Immediate Treatment
Participants in the IT group receive the 8-week MENTOR program
Delayed Treatment
Participants in the DT group have an 8-week waitlist period before starting the MENTOR program
Retention
Participants undergo an 8-week retention period after completing the MENTOR program
Follow-up
Participants are monitored for outcomes such as stress, resilience, and quality of life
Treatment Details
Interventions
- MENTOR Program (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Dr. Alec C. Kimmelman
NYU Langone Health
Chief Executive Officer
MD and PhD from Mount Sinai School of Medicine
Dr. Nicole M. Adler
NYU Langone Health
Chief Medical Officer since 2023
MD
University of Alabama at Birmingham (UAB) Wellness, Health and Research Facility (WHARF)
Collaborator
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator
Dr. Kristi Hill
National Institute on Disability, Independent Living, and Rehabilitation Research
Acting Director since 2012
PhD in Neuroscience from the Medical College of Virginia
Dr. Phillip Beatty
National Institute on Disability, Independent Living, and Rehabilitation Research
Director of the Office of Research Sciences since 2019
PhD in Rehabilitation Sciences